Equillium Net Worth

Equillium Net Worth Breakdown

  EQ
The net worth of Equillium is the difference between its total assets and liabilities. Equillium's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Equillium's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Equillium's net worth can be used as a measure of its financial health and stability which can help investors to decide if Equillium is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Equillium stock.

Equillium Net Worth Analysis

Equillium's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Equillium's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Equillium's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Equillium's net worth analysis. One common approach is to calculate Equillium's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Equillium's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Equillium's net worth. This approach calculates the present value of Equillium's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Equillium's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Equillium's net worth. This involves comparing Equillium's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Equillium's net worth relative to its peers.

Enterprise Value

2.58 Million

To determine if Equillium is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Equillium's net worth research are outlined below:
Equillium generated a negative expected return over the last 90 days
Equillium has high historical volatility and very poor performance
Equillium may become a speculative penny stock
The company generated the yearly revenue of 36.08 M. Annual Net Loss to common stockholders was (13.34 M) with gross profit of 15.76 M.
Equillium reports about 57.56 M in cash with (21.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Equillium has a very weak financial position based on the latest SEC disclosures
Roughly 36.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Markets EQ Unveils Strategic Purchase of Voice AI Trailblazer Helios Life Enterprises
Equillium uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Equillium. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Equillium's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Equillium's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Equillium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Equillium backward and forwards among themselves. Equillium's institutional investor refers to the entity that pools money to purchase Equillium's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Integrated Wealth Concepts Llc2023-12-31
40 K
Northern Trust Corp2023-12-31
35.2 K
Prudential Financial Inc2024-03-31
31.2 K
Capital Cs Group, Llc2023-12-31
19 K
Jane Street Group, Llc2023-12-31
12 K
Tower Research Capital Llc2023-12-31
9.4 K
Adar1 Capital Management Llc2023-12-31
6.5 K
Simplex Trading, Llc2024-03-31
5.2 K
Blackrock Inc2023-12-31
3.8 K
Decheng Capital Llc2023-12-31
4.4 M
Vanguard Group Inc2024-03-31
841.9 K
Note, although Equillium's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Equillium's market capitalization trends

The company currently falls under 'Micro-Cap' category with a market capitalization of 55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Equillium's market, we take the total number of its shares issued and multiply it by Equillium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

23.85 Million

Project Equillium's profitablity

Equillium's profitability indicators refer to fundamental financial ratios that showcase Equillium's ability to generate income relative to its revenue or operating costs. If, let's say, Equillium is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Equillium's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Equillium's profitability requires more research than a typical breakdown of Equillium's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.26)(0.28)
Return On Capital Employed(0.63)(0.66)
Return On Assets(0.26)(0.28)
Return On Equity(0.59)(0.62)
The company has Net Profit Margin (PM) of (0.32) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.26) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.26.
When accessing Equillium's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Equillium's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Equillium's profitability and make more informed investment decisions.
The data published in Equillium's official financial statements usually reflect Equillium's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Equillium. For example, before you start analyzing numbers published by Equillium accountants, it's critical to develop an understanding of what Equillium's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Equillium's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Equillium's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Equillium's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Equillium. Please utilize our Beneish M Score to check the likelihood of Equillium's management manipulating its earnings.

Evaluate Equillium's management efficiency

Equillium has Return on Asset (ROA) of (0.1431) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1431. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.4817) %, which implies that it produced no returns to current stockholders. Equillium's management efficiency ratios could be used to measure how well Equillium manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/21/2024, Return On Tangible Assets is likely to drop to -0.28. In addition to that, Return On Capital Employed is likely to drop to -0.66. At this time, Equillium's Total Current Liabilities is relatively stable compared to the past year. As of 05/21/2024, Liabilities And Stockholders Equity is likely to grow to about 67.5 M, while Non Current Liabilities Total is likely to drop slightly above 364.8 K.
Last ReportedProjected for Next Year
Book Value Per Share 0.65  0.62 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 0.65  0.62 
Enterprise Value Over EBITDA(0.19)(0.20)
Price Book Value Ratio 1.11  1.53 
Enterprise Value Multiple(0.19)(0.20)
Price Fair Value 1.11  1.53 
Enterprise Value2.7 M2.6 M
The analysis of Equillium's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Equillium's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Equillium Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue
0.7369
Revenue
37.9 M
Quarterly Revenue Growth
0.204
Revenue Per Share
1.085
Return On Equity
(0.48)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Equillium insiders, such as employees or executives, is commonly permitted as long as it does not rely on Equillium's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Equillium insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Equillium time-series forecasting models is one of many Equillium's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Equillium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Equillium Earnings per Share Projection vs Actual

Be your own money manager

Our tools can tell you how much better you can do entering a position in Equillium without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Equillium Corporate Management

Elected by the shareholders, the Equillium's board of directors comprises two types of representatives: Equillium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Equillium. The board's role is to monitor Equillium's management team and ensure that shareholders' interests are well served. Equillium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Equillium's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason KeyesChief OfficerProfile
Matthew RitterSenior DevelopmentProfile
Penny TomPrincipal OfficerProfile
Maple MDChief OfficerProfile
Krishna MDConsultantProfile

How to buy Equillium Stock?

The net worth of Equillium is the difference between its total assets and liabilities. Equillium's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Equillium's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Equillium's net worth can be used as a measure of its financial health and stability which can help investors to decide if Equillium is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Equillium stock.

Already Invested in Equillium?

The danger of trading Equillium is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Equillium is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Equillium. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Equillium is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.35)
Revenue Per Share
1.085
Quarterly Revenue Growth
0.204
Return On Assets
(0.14)
Return On Equity
(0.48)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.